[1
]From the UCSF Weill Institute for Neurosciences, Department of Neurology, University
of California, San Francisco, San Francisco (S.L.H.); the Center for Neuroinflammation
and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine,
University of Pennsylvania, Philadelphia (A.B.-O.); the Department of Neurology, Mellen
Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland
(J.A.C.); the Institute of Experimental Neurology and Multiple Sclerosis...